LIXTE Biotechnology Raises $1.05M in Direct Offering to Advance Corporate Growth

Retrieved on: 2025-02-13 15:38:39

Tags for this article:

Click the tags to see associated articles and topics

LIXTE Biotechnology Raises $1.05M in Direct Offering to Advance Corporate Growth. View article details on hiswai:

Excerpt

LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules. Rhea-AI Impact.

Article found on: www.stocktitan.net